WITHDRAWAL OF THIOPURINES IN INFLAMMATORY BOWEL DISEASE PATIENTS IN STABLE REMISSION: A PROSPECTIVE, MULTICENTER COHORT STUDY

Edo Savelkoul  ¹     Remi Mahmoud  ²     Dirk De Jong  ²     Willemijn Van Dop  ²     Tessa E.H. Römkens  ³     Loes Nissen  ³     Nofel Mahmmod  ⁴     Petra van Boeckel  ⁵     Maurice Lutgens  ⁶     Wout Mares  ⁷     Ludger S.M. Epping Stippel  ⁸     Itta Minderhoud  ⁹     Jeroen Michiel Jansen  ¹⁰     Ingrid Gisbertz  ¹¹     Paul Boekema  ¹²     Daan De Koning  ¹³     Carmen Horjus Talabur Horje  ¹⁴     Bindia Jharap  ¹⁵     Bas Oldenburg  ¹⁵     Frank Hoentjen  ^16    
1 Radboudumc, Nijmegen, Netherlands
² University Medical Center Utrecht, Utrecht, Netherlands
³ Jeroen Bosch Hospital, Den Bosch, Netherlands
⁴ Antonius Ziekenhuis, Zeist, Netherlands
⁵ Antonius Ziekenhuis, Nieuwegein, Netherlands
⁶ Elisabeth-TweeSteden Hospital, Tilburg, Netherlands
⁷ Hospital Gelderse Vallei, Ede, Netherlands
⁸ Maasziekenhuis Pantein, Boxmeer, Netherlands
⁹ Tergooi Medical Centre, Hilversum, Netherlands
¹⁰ Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands
¹¹ Bernhoven Hospital, Uden, Netherlands
¹² Maxima Medical Centre, Veldhoven, Netherlands
¹³ Gelre Hospital, Apeldoorn, Netherlands
¹⁴ Rijnstate Hospital, Arnhem, Netherlands
¹⁵ Meander Medical Centre, Amersfoort, Netherlands
¹⁶ University of Alberta, Edmonton, Canada

Topic
IBD, Nurses

Session
Old and new molecules in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)